Tags

Type your tag names separated by a space and hit enter

1 - year follow-up after intravitreal bevacizumab alone and in combination with photodynamic therapy for AMD and PCV.
Acta Ophthalmol 2011; 89(4):e373AO

Authors

No affiliation info available

Pub Type(s)

Letter

Language

eng

PubMed ID

21040503

Citation

Forte, Raimondo. "1 - Year Follow-up After Intravitreal Bevacizumab Alone and in Combination With Photodynamic Therapy for AMD and PCV." Acta Ophthalmologica, vol. 89, no. 4, 2011, pp. e373.
Forte R. 1 - year follow-up after intravitreal bevacizumab alone and in combination with photodynamic therapy for AMD and PCV. Acta Ophthalmol. 2011;89(4):e373.
Forte, R. (2011). 1 - year follow-up after intravitreal bevacizumab alone and in combination with photodynamic therapy for AMD and PCV. Acta Ophthalmologica, 89(4), pp. e373. doi:10.1111/j.1755-3768.2010.01991.x.
Forte R. 1 - Year Follow-up After Intravitreal Bevacizumab Alone and in Combination With Photodynamic Therapy for AMD and PCV. Acta Ophthalmol. 2011;89(4):e373. PubMed PMID: 21040503.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - 1 - year follow-up after intravitreal bevacizumab alone and in combination with photodynamic therapy for AMD and PCV. A1 - Forte,Raimondo, Y1 - 2010/10/07/ PY - 2010/11/3/entrez PY - 2010/11/3/pubmed PY - 2011/9/2/medline SP - e373 EP - e373 JF - Acta ophthalmologica JO - Acta Ophthalmol VL - 89 IS - 4 SN - 1755-3768 UR - https://www.unboundmedicine.com/medline/citation/21040503/1___year_follow_up_after_intravitreal_bevacizumab_alone_and_in_combination_with_photodynamic_therapy_for_AMD_and_PCV_ L2 - https://doi.org/10.1111/j.1755-3768.2010.01991.x DB - PRIME DP - Unbound Medicine ER -